Literature DB >> 29657453

Periprosthetic hip fractures: A review of the economic burden based on length of stay.

Rebecca F Lyons1, Robert P Piggott1, William Curtin1, Colin G Murphy1.   

Abstract

INTRODUCTION: With the increasing rates of total hip replacements being performed worldwide, there is an increasing incidence of periprosthetic fractures. As our patients' demographics change to include older patients with multiple medical co-morbidities, there is a concurrent increase in morbidity and mortality rates. This leads to longer hospital stays and increasing hospital costs. In the current economic climate, the cost of treating periprosthetic fractures must be addressed and appropriate resource and funding allocation for future provision of services should be planned.
MATERIALS AND METHODS: All periprosthetic hip fractures that were admitted to a single trauma unit over a three-year period were reviewed. Independent chart review, haematological and radiological review was undertaken. All patients with a periprosthetic fracture associated with a total hip arthroplasty or hemiarthroplasty were included. Follow up data including complications were collated. Data from the hospital inpatient database and finance department was utilized for cost analysis. All statistical analysis was preformed using Minitab version 17.
RESULTS: 48 patients were identified who met the inclusion criteria for review. The majority of participants were female with a mean age of 73.5 years. The mean time to fracture was 4.5 years (9 months-18.5 years). Periprosthetic fracture was associated with total hip arthroplasty in 24 cases and a Vancouver B2 classification was most common at n = 20. The majority of patients had revision arthroplasty, with a mean length of stay of 24 days for the whole cohort (9-42). Vancouver B3 fractures had the longest inpatient stay at a mean of 26 days. The mean cost of for a full revision of stem with additional plate and cable fixation was over €27000 compared to €14,600 for ORIF and cable fixation based on length of hospital stay.
CONCLUSION: The prolonged length of stay associated with Vancouver B2 and B3 fractures leads to increased costs to the healthcare service. Accurately calculating the costs of total treatment for periprosthetic fractures is difficult due to a lack of transparency around implant and staffing costs. However, as we can expect increasing incidence of periprosthetic fractures presenting in the coming years it is paramount that we make financial provisions within healthcare budgets to ensure we can treat these patients appropriately.

Entities:  

Keywords:  Cost; Length of stay; Periprosthetic fracture

Year:  2018        PMID: 29657453      PMCID: PMC5895931          DOI: 10.1016/j.jor.2018.01.006

Source DB:  PubMed          Journal:  J Orthop        ISSN: 0972-978X


  11 in total

1.  Economic burden of revision hip and knee arthroplasty in Medicare enrollees.

Authors:  K L Ong; F S Mowat; N Chan; E Lau; M T Halpern; S M Kurtz
Journal:  Clin Orthop Relat Res       Date:  2006-05       Impact factor: 4.176

2.  Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030.

Authors:  Steven Kurtz; Kevin Ong; Edmund Lau; Fionna Mowat; Michael Halpern
Journal:  J Bone Joint Surg Am       Date:  2007-04       Impact factor: 5.284

3.  What is the financial cost of treating periprosthetic hip fractures?

Authors:  J R A Phillips; C Boulton; C G Morac; A R J Manktelov
Journal:  Injury       Date:  2011-02       Impact factor: 2.586

4.  Implant selection and cost for total joint arthroplasty: conflict between surgeons and hospitals.

Authors:  William L Healy; Richard Iorio
Journal:  Clin Orthop Relat Res       Date:  2007-04       Impact factor: 4.176

Review 5.  Enhanced rehabilitation and care models for adults with dementia following hip fracture surgery.

Authors:  Toby O Smith; Yasir A Hameed; Jane L Cross; Catherine Henderson; Opinder Sahota; Chris Fox
Journal:  Cochrane Database Syst Rev       Date:  2015-06-15

6.  A financial analysis of revision hip arthroplasty: the economic burden in relation to the national tariff.

Authors:  I S Vanhegan; A K Malik; P Jayakumar; S Ul Islam; F S Haddad
Journal:  J Bone Joint Surg Br       Date:  2012-05

7.  Functional outcome of femoral peri prosthetic fracture and revision hip arthroplasty: a matched-pair study from the New Zealand Registry.

Authors:  Simon W Young; Cameron G Walker; Rocco P Pitto
Journal:  Acta Orthop       Date:  2008-08       Impact factor: 3.717

Review 8.  Periprosthetic femoral fractures--incidence, classification problems and the proposal of a modified classification scheme.

Authors:  Stephan Frenzel; Vilmos Vécsei; Lukas Negrin
Journal:  Int Orthop       Date:  2015-09-02       Impact factor: 3.075

9.  Vancouver type B2 and B3 periprosthetic fractures treated with revision total hip arthroplasty.

Authors:  Tomas Amenabar; Wael A Rahman; Vineet V Avhad; Ramiro Vera; Allan E Gross; Paul R Kuzyk
Journal:  Int Orthop       Date:  2015-08-25       Impact factor: 3.075

10.  The multidisciplinary management of hip fractures in older patients.

Authors:  Anna H K Riemen; James D Hutchison
Journal:  Orthop Trauma       Date:  2016-04
View more
  3 in total

1.  Inter-implant fractures: an unmet medical need-a preventive approach proposal.

Authors:  David Campillo-Recio; Miquel Videla-Ces; Miquel Sales-Pérez; Guillem Molina-Olivella; Sebastian Videla
Journal:  Eur J Orthop Surg Traumatol       Date:  2019-10-22

2.  Medical resource utilization and costs for intraoperative and early postoperative periprosthetic hip fractures following total hip arthroplasty in the medicare population: A retrospective cohort study.

Authors:  Abhishek Shirish Chitnis; Jack Mantel; Mollie Vanderkarr; Matthew Putnam; Jill Ruppenkamp; Chantal Elisabeth Holy; Joshua Bridgens
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

3.  Do standards of care and early outcomes of periprosthetic fractures change during the COVID-19 pandemic? A multicentre study.

Authors:  Luigi Zagra; Rocco D'Apolito; Nicola Guindani; Giovanni Zatti; Fabrizio Rivera; Flavio Ravasi; Mario Mosconi; Alberto Momoli; Alessandro Massè; Massimo Franceschini; Fabio D'Angelo; Dante Dallari; Fabio Catani; Alessandro Casiraghi; Federico Bove; Claudio Carlo Castelli
Journal:  J Orthop Traumatol       Date:  2021-06-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.